The Chemours Company reported $5.80B of revenue over the trailing twelve months, −0.92% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $5.80B (to Q2 2026). Net Income: −$304M, trailing twelve months to Q2 2026. Free Cash Flow: $218M, trailing twelve months to Q2 2026. Op Margin: −1.6%, trailing twelve months to Q2 2026.

CCThe Chemours Company

Basic MaterialsUSD

$15.78

$10.3952 weeks$27.84

CC as reported

The Chemours Company reported $5.80B of revenue over the trailing twelve months, −0.92% on the year before. 11 reported series are charted on this page, each one as filed.

$5.80B

Revenue, trailing twelve months · to Q2 2026 · −0.92% against the twelve months before

Net Income: −$304M
Net Income · −29% year on year · trailing twelve months to Q2 2026
Free Cash Flow: $218M
Free Cash Flow · −504% year on year · trailing twelve months to Q2 2026
Op Margin: −1.6%
Op Margin · trailing twelve months to Q2 2026

Every series Ryufin has for CC, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$5.80B	−0.92%	Q2 2026
Net Income	−$304M	−29%	Q2 2026
EPS	−$2.00	−30%	Q2 2026
Gross Margin	15%	n/a	Q2 2026
Op Margin	−1.6%	n/a	Q2 2026
Net Margin	−4.9%	n/a	Q2 2026
ROE	37%	n/a	Q2 2026
ROA	−4.9%	n/a	Q2 2026
ROIC	−1.5%	n/a	Q2 2026
Free Cash Flow	$218M	−504%	Q2 2026
P/E	82.8	n/a	Q1 2025 · 5 quarters behind